(Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways
Eugene Varfolomeev1, Domagoj Vucic
1Department of Protein Engineering, Genentech, Inc. South San Francisco, California 94080, USA.
Abstract:
A family of anti-apoptotic regulators known as inhibitor of apoptosis (IAP) proteins block cell death in response to diverse stimuli. In spite of the fact that cellular IAP1 and 2 (c-IAP1 and 2) were discovered more than 12 years ago, their physiological roles have remained obscure. Several molecular mechanisms were proposed to explain their anti-apoptotic activity, ranging from direct inhibition and ubiquitination of pro-apoptotic molecules, to the activation of pro-survival signaling. New findings present a surprising and complex twists. On the one hand, cIAP1 and c-IAP2 suppress Tumor Necrosis Factor alpha (TNFalpha) stimulated cell death by preventing formation of the TNF Receptor 1 (TNFR1) pro-apoptotic signaling complex. On the other hand, they regulate pro-survival NFkappaB signaling pathways: in the non-canonical pathway, by ubiquitination of NFkappaB-inducing kinase (NIK), and in the canonical pathway, by a yet-to-be-defined mechanism. In addition, c-IAPs self-regulate their protein levels through RING domain mediated auto-ubiquitination. Here, we discuss the most recent progress in our understanding of the biological roles of c-IAPs, as well as the implications of targeting c-IAPs for therapeutic intervention.
Insights
Inhibitor of apoptosis (IAP) proteins regulate cell death. Cellular IAP1 and 2 (c-IAP1/2) suppress TNFalpha-induced cell death and regulate NFkappaB signaling, offering therapeutic potential.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Inhibitor of apoptosis (IAP) proteins are key regulators of cell death pathways.
- Cellular IAP1 and 2 (c-IAP1/2) have known anti-apoptotic functions but their precise physiological roles remain largely undefined.
- Proposed mechanisms for IAP anti-apoptotic activity include direct inhibition and ubiquitination of pro-apoptotic factors, and activation of pro-survival signaling.
Purpose of the Study:
- To elucidate the complex biological roles of c-IAP1 and c-IAP2.
- To review recent advancements in understanding c-IAP1/2 functions.
- To discuss the therapeutic implications of targeting c-IAPs.
Main Methods:
- Review of recent scientific literature on c-IAP1/2.
- Analysis of molecular mechanisms underlying c-IAP1/2 function.
- Discussion of signaling pathways involving c-IAP1/2, including TNFalpha and NFkappaB pathways.
Main Results:
- c-IAP1/2 suppress Tumor Necrosis Factor alpha (TNFalpha)-stimulated cell death by inhibiting the formation of the TNF Receptor 1 (TNFR1) pro-apoptotic signaling complex.
- c-IAP1/2 regulate pro-survival NFkappaB signaling pathways, including ubiquitination of NFkappaB-inducing kinase (NIK) in the non-canonical pathway.
- c-IAPs exhibit self-regulation of protein levels via RING domain-mediated auto-ubiquitination.
Conclusions:
- c-IAP1/2 play multifaceted roles in both suppressing apoptosis and regulating pro-survival signaling.
- Understanding these complex roles is crucial for developing targeted therapies.
- Targeting c-IAPs presents a promising avenue for therapeutic intervention in various diseases.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Caspases
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Apoptosis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


